Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (51-60 of 251) with videos related to

Pageof 26
Sort By:
Rheumatology (Oxford, England)|September 17, 2008
Pulmonary function testsJ Behr, D E Furst
Rheumatology (Oxford, England)|April 27, 2007
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?K Brune, D E Furst
Arthritis and Rheumatism|June 1, 1993
Differential effects of diclofenac and aspirin on serum glutamic oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritisD E Furst, W Anderson
Drugs & Aging|December 1, 1995
Disease-modifying antirheumatic drugs. Potential effects in older patientsG Gardner, D E Furst
Current Opinion in Rheumatology|April 1, 1990
Recent clinical pharmacology and clinical trial reportsM A Catalano, D E Furst
Annals of the Rheumatic Diseases|September 23, 2010
Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapyK L Winthrop, D E Furst
Expert Opinion on Pharmacotherapy|March 16, 2001
RofecoxibJ L Hillson, D E Furst
Arthritis and Rheumatism|April 1, 1992
Decreased hemoglobin levels in nonsteroidal antiinflammatory drug-treated patients may not be related to the drugD I Cargill, D E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
Hypothesis for the pathogenesis of systemic sclerosisD E Furst, P J Clements
Arthritis and Rheumatism|March 1, 1988
Methotrexate in rheumatoid arthritisD E Furst, J M Kremer
Pageof 26

Showing results (51-60 of 251) with videos related to

Sort By:
Pageof 26
Rheumatology (Oxford, England)|September 17, 2008
Pulmonary function testsJ Behr, D E Furst
Rheumatology (Oxford, England)|April 27, 2007
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?K Brune, D E Furst
Arthritis and Rheumatism|June 1, 1993
Differential effects of diclofenac and aspirin on serum glutamic oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritisD E Furst, W Anderson
Drugs & Aging|December 1, 1995
Disease-modifying antirheumatic drugs. Potential effects in older patientsG Gardner, D E Furst
Current Opinion in Rheumatology|April 1, 1990
Recent clinical pharmacology and clinical trial reportsM A Catalano, D E Furst
Annals of the Rheumatic Diseases|September 23, 2010
Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapyK L Winthrop, D E Furst
Expert Opinion on Pharmacotherapy|March 16, 2001
RofecoxibJ L Hillson, D E Furst
Arthritis and Rheumatism|April 1, 1992
Decreased hemoglobin levels in nonsteroidal antiinflammatory drug-treated patients may not be related to the drugD I Cargill, D E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
Hypothesis for the pathogenesis of systemic sclerosisD E Furst, P J Clements
Arthritis and Rheumatism|March 1, 1988
Methotrexate in rheumatoid arthritisD E Furst, J M Kremer
Pageof 26